Study of Fecalibacteria prausntzii in Egyptian patients with inflammatory bowel disease

Study of Fecalibacteria prausntzii in Egyptian patients with inflammatory bowel disease

Saved in:

Bibliographic Details
Main Authors:	Khaled Abd El Atty, Hanan Nouh, Shwikar Abdelsalam, Ahmed Ellakany, Hany Abdaalah, Doaa Header
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-05-01
Series:	Gastroenterology Review
Subjects:	crohn’s disease ulcerative colitis faecalibacterium prausnitzii.
Online Access:	https://www.termedia.pl/Study-of-Fecalibacteria-prausntzii-in-Egyptian-patients-with-inflammatory-bowel-disease,41,54095,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Faecalibacterium prausnitzii regulates carbohydrate metabolic functions of the gut microbiome in C57BL/6 mice
by: Peiling Geng, et al.
Published: (2025-12-01)

The current standard of care of inflammatory bowel disease
by: J Wright
Published: (2024-03-01)

Thrombotic Complications in Inflammatory Bowel Disease
by: A. V. Borota, et al.
Published: (2019-05-01)

Leukocytapheresis in patients with inflammatory bowel diseases
by: Małgorzata Woźniak, et al.
Published: (2021-06-01)

Sources of Bias in Common Diagnosis of Chronic Inflammatory Bowel Diseases
by: O. A. Svatkova, et al.
Published: (2020-12-01)

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
by: Małgorzata Woźniak, et al.
Published: (2019-03-01)

Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases
by: Katarzyna B. Biernacka, et al.
Published: (2019-03-01)

Telocytes in inflammatory bowel diseases: contributions to pathology and therapeutic potentials
by: Ronaldo Paolo Panganiban, et al.
Published: (2025-01-01)

Clinical features, treatment, and prognosis of secukinumab-induced inflammatory bowel disease
by: Ronghui Li, et al.
Published: (2025-01-01)

The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease
by: P. Rutgeerts
Published: (1998-01-01)

Using Dose-Effect Relationship for Optimising Systemic Corticosteroid Dosage in Treatment of Inflammatory Bowel Diseases
by: O. P. Alekseeva, et al.
Published: (2020-12-01)

An Analysis of the Effectiveness and Safety of Upadacitinib in the Treatment of Inflammatory Bowel Disease: A Multicenter Real-World Study
by: Hongzhen Wu, et al.
Published: (2025-01-01)

Contents of plasma М2-pyruvate kinase (M2-РК) in patients with inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2010-11-01)

Modern Approaches in the Morphological Diagnosis of Inflammatory Bowel Diseases
by: A. S. Tertychnyy, et al.
Published: (2022-08-01)

Correlation of mental and psychological status with disease activity in patients with inflammatory bowel disease using SCL-90 R Questionnaire
by: Ezzat Ali, et al.
Published: (2024-05-01)

Thiamine-Reduced Fatigue in Quiescent Inflammatory Bowel Disease Is Linked to Faecalibacterium prausnitzii Abundance
by: Sandra Bermúdez-Sánchez, et al.
Published: (2025-01-01)

Evaluation of the Clinical Efficacy of Prednisolone in the Treatment of Inflammatory Bowel Diseases with Different Dosage Methods
by: O. P. Alekseeva, et al.
Published: (2023-05-01)

The Influence of Physical Activity on Inflammatory Markers, Intestinal Microbiota Composition and Disease Activity in Inflammatory Bowel Disease
by: Paulina Jakubczyk, et al.
Published: (2025-01-01)

Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2015-05-01)

Inflammatory bowel disease – one entity with many molecular faces
by: Sylwia Szymańska, et al.
Published: (2019-12-01)

Inflammatory Bowel Disease and Statins
by: V. V. Genkel, et al.
Published: (2020-04-01)

Medical and social rehabilitation of patients and disabled persons with inflammatory bowel diseases
by: K. A. Velikolug, et al.
Published: (2011-09-01)

Mucocutaneous Manifestations Reported by Inflammatory Bowel Disease Patients in University Hospital
by: Ieva Renata Jonaitytė, et al.
Published: (2024-09-01)

The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy. A preliminary report
by: Agata Rudnik, et al.
Published: (2019-01-01)

Analysis of risk factors of Clostridioides difficile infection in patients with inflammatory bowel disease
by: Alicja Jakubowska, et al.
Published: (2024-09-01)

Dual Biologic or Small Molecule Therapy in Pediatric Inflammatory Bowel Disease: A Single Center Experience
by: Cheng Guo, et al.
Published: (2025-01-01)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01)

Pathogenetic Aspects of Oral Cavity Lesions in Inflammatory Gastrointestinal Tract Diseases
by: N. S. Robakidze, et al.
Published: (2019-09-01)

Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization
by: Qiang Su, et al.
Published: (2025-01-01)

Course of COVID-19 in Patients with Inflammatory Bowel Disease: Regional Experience
by: L. M. Kupkenova, et al.
Published: (2023-02-01)

Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey
by: Ailsa Hart, et al.
Published: (2024-12-01)

Diagnosis and management of de novo inflammatory bowel disease after solid organ transplantation in the era of biologic therapy: a case series
by: Willie Mohammed Johnson, et al.
Published: (2025-01-01)

Specific Features of Vascular Endothelium in Patients with Severe Forms of Inflammatory Bowel Diseases
by: O. V. Khlynova, et al.
Published: (2018-11-01)

Investigating the Activity Status of Inflammatory Bowel Disease and its Related Factors: A Study Protocol
by: Mehrnaz Asgharnezhad, et al.
Published: (2025-01-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)

Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
by: Renata d’Inca, et al.
Published: (2025-01-01)

Mendelian randomization analysis reveals genetic evidence for a causal link between inflammatory bowel disease and uterine cervical neoplasms
by: Chunge Cao, et al.
Published: (2025-01-01)

Prevalence and predictors of small intestinal bacterial overgrowth in inflammatory bowel disease: a meta-analysis
by: Xin Feng, et al.
Published: (2025-01-01)

Features of development and progression of colorectal cancer on a background of ulcerative colitis
by: I. L. Khalif, et al.
Published: (2012-02-01)

Inflammatory bowel disease increases the risk of pancreatitis: a two-sample bidirectional Mendelian randomization analysis
by: Li-Hui Fang, et al.
Published: (2025-01-01)